Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/4/25 17:05 | 3/3/25 | AKBA | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | 5 | S.d | -597 | 1.86 | 0 | -321 | 2,924 | D | |||||||||||||||
3/4/25 17:04 | 3/3/25 | AKBA | Health | Drug | Pharmaceutical Preparations | Burke Steven Keith | MA | O | SVP,Chie | 6 | S.d | -215 | 1.73 | 0 | -124 | 816 | D | |||||||||||||||
2/4/25 17:52 | 2/3/25 | AKBA | Health | Drug | Pharmaceutical Preparations | Malabre Richard C | MA | O | SVP,Chie | 1 | S.d | -63 | 2.10 | 0 | -30 | 280 | D | |||||||||||||||
2/4/25 17:51 | 2/3/25 | AKBA | Health | Drug | Pharmaceutical Preparations | Grund Nicholas | MA | O | Chief Co | 1 | S.d | -117 | 2.10 | 0 | -56 | 443 | D | |||||||||||||||
5/14/24 16:05 | 5/13/24 | AKBA | Health | Drug | Pharmaceutical Preparations | Hadas Nicole R. | MA | O | SVP,GC | 3 | S | -36 | 1.41 | 0 | -25 | 669 | D | |||||||||||||||
5/14/24 16:04 | 5/13/24 | AKBA | Health | Drug | Pharmaceutical Preparations | Dahan Michel | MA | O | SVP,COO | 3 | S | -74 | 1.36 | 0 | -54 | 716 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |